Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Catella is a prominent Swedish financial group that provides specialized investment management and advisory services within the healthcare and life sciences sectors. The firm operates through two primary pillars: healthcare real estate and life science corporate finance. Its real estate division, notably through Catella Healthcare in France and the Catella Focus Healthcare fund in Germany, manages extensive portfolios of healthcare infrastructure, including nursing homes, clinics, and senior housing across Europe. Simultaneously, Catella’s corporate finance arm is a leading advisor for the Nordic biotech and medtech industries, having facilitated numerous IPOs, capital raises, and M&A transactions for companies such as Hansa Biopharma and Oncopeptides. Headquartered in Stockholm and listed on Nasdaq Stockholm, Catella serves as a critical intermediary between institutional investors and the healthcare innovation and infrastructure markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Catella Healthcare Investments.